Renal Impairment Labeling Updates for Sofosbuvir-Based HCV Therapies

The FDA has approved updated labeling for Epclusa (sofosbuvir/velpatasvir), Harvoni (ledipasvir/sofosbuvir) and Vosevi (sofosbuvir/velpatasvir/voxilaprevir) to include updated information regarding treatment of patients with hepatitis C virus (HCV) who have severe renal impairment including those with end stage renal disease who are on dialysis.

Genetic Test Identifies Hereditary CKD

Whole exome sequencing, a technique for sequencing the protein-coding genes in the genome, can identify multiple potential genetic causes of inherited kidney disease, according to investigators. Their study of exome sequencing and diagnostic analysis involving 2 cohorts totaling 3315 patients with chronic kidney disease (CKD) detected diagnostic variants in 307 patients (9.3%). Of these, 206…

Join State of the Art Hospital’s Urology Practice in Taos, NM

WONDERFUL UROLOGY OPPORTUNITY in TAOS, NEW MEXICO …The Land of Enchantment! This is a hospital employed position offering TREMENDOUS SALARY + bonus. The comprehensive health benefits are generous including: paid malpractice insurance; health benefits; staff dues; relocation, CME stipend with paid time off. Our client is looking for a Board Certified/Board Eligible Urologist to join…

Kidney Week Video Survey: Antonino Sidoti, MD

Antonino Sidoti, MD gives us his opinion on our survey question “Do you think many CKD patients are being placed on dialysis too soon?” with a “European point of view” and how nephrologists should largely consider comorbidities.

Next post in Uncategorized